Katalin Jakab

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 177 citations · Full text

Effectiveness of a Three-Week Inpatient Pulmonary Rehabilitation Program for Patients after COVID-19: A Prospective Observational Study

Markus Hayden, Matthias Limbach, Michael Schüler et al. · International Journal of Environmental Research and Public Health · 2021 · 98 citations · Full text

Pulmonary Care, Advanced Lung Disease, Acute Phase +16

Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia

Éva Karászi, Katalin Jakab, László Homolya et al. · British Journal of Haematology · 2001 · 78 citations · Full text

Apolipoprotein E polymorphism in Pick’s disease and in Huntington’s disease

János Kálmán, Anna Juhász, Katalin Majtényi et al. · Neurobiology of Aging · 2000 · 38 citations

Apolipoprotein E Polymorphism, Neurodegenerative Diseases, Genetic Disorder +7

A P-gp vesicular transport inhibition assay – Optimization and validation for drug–drug interaction testing

Krisztina Herédi‐Szabó, Johan Palm, Tommy B. Andersson et al. · European Journal of Pharmaceutical Sciences · 2013 · 36 citations

Pharmaceutical Science, Drug Target, Drug–drug Interaction +7